Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs

Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors […]

© 2024 TechCrunch. All rights reserved. For personal use only.

advances affiliate ai drug discovery ai for biotech arch arch venture partners big biotech biotech & health capital computational discovery drug discovery drugs foresite capital generative investors labs making massive partners startup startups storm tech tuesday venture world xaira